Richard Pulik - 20 Aug 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: CFO
Issuer ticker: ROIV
Reported as of: 20 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Aug 2026, 21:00:21 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Richard Pulik

Key filing fact

Richard Pulik filed Form 4 for Roivant Sciences Ltd. (ROIV) on 24 Aug 2026.

Key facts

This page summarizes Richard Pulik's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Aug 2026, 21:00.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001885841 Primary reporting owner

Pulik Richard

Relationship: CFO
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Richard Pulik
Signature date: 24 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Tax liability

Transaction value
Shares: -5,749
Change %: -2.1%
Price: $36.84^*
Shares after: 271,810
Date: 20 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Footnote F2

Includes Common Shares purchased under the Issuer's Employee Stock Purchase Plan.

SEC remarks

Exhibit 24 - Power of Attorney